ADVERTISEMENT

Halep 'confident' of overturning doping ban after CAS hearing

Published Feb 10, 2024 06:19 am

At A Glance

  • Former world number one Simona Halep said on Friday, Feb. 9, she was confident her appeal against a four-year doping ban would be successful after a three-day hearing before the Court of Arbitration for Sport in Switzerland.

LAUSANNE (AFP) -- Former world number one Simona Halep said on Friday, Feb. 9, she was confident her appeal against a four-year doping ban would be successful after a three-day hearing before the Court of Arbitration for Sport in Switzerland.

AFP__20240207__34HR66N__v1__HighRes__TennisRomDopingJusticeHalep.jpg
Former world number one tennis player Romania's Simona Halep (center) arrives at the Court of Arbitration for Sport in Lausanne last Wednesday, Feb. 7, for her appeal against a four-year doping ban. The two-time Grand Slam singles champion tested positive for roxadustat after the US Open in 2022 and was charged with a separate second anti-doping breach last year relating to irregularities in her athlete biological passport. (AFP)

"This hearing provided me with the opportunity to present my position and defend my innocence," the two-time Grand Slam winner said in a statement after the final day of the hearing.

"My confidence in the prevalence of the truth remains intact. I look forward to reclaiming my place on the tennis courts."

Accompanied by her lawyers, the 32-year-old began pleading her case behind closed doors at CAS headquarters in Lausanne on Wednesday.

The hearing concluded on Friday at 1430GMT "with the final pleadings of the parties", CAS said in a separate statement.

"The parties have been informed that the CAS Panel in charge of the matter will now deliberate and prepare the Arbitral Award containing its decision and grounds," the statement added.

The CAS ruling will be delivered at a date yet to be announced.

The Romanian was suspended last September by the International Tennis Integrity Agency (ITIA) after two separate doping infractions.

She tested positive for roxadustat after the US Open in 2022 and was charged with a second anti-doping breach last year relating to irregularities in her athlete biological passport.

Halep has protested her innocence and refused to accept the ITIA decision which will keep her from playing professional tennis again until October 6, 2026.

The winner of the 2018 French Open and 2019 Wimbledon singles titles says she wants to "clear her name" and has claimed experts found she had accidentally taken a contaminated supplement.

Roxadustat is a substance that can be used legitimately to treat anemia.

But it is also on the World Anti-Doping Agency banned list as it is considered a blood-doping agent, which increases hemoglobin and the production of red blood cells.

The biological passport system is designed for the long-term monitoring of an athlete's blood indicators with the aim of identifying irregularities that could indicate doping.

Halep is the first leading women's tennis player to be caught in the anti-doping net since the suspension of Russian Maria Sharapova in 2016.

Related Tags

Simona Halep
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.